InsiderTrades.com logo

LONA Insider Trading

Insider Ownership Percentage: 25.07%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $48,920.70

Athira Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Athira Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Athira Pharma Share Price & Price History

Current Price: $5.37
Price Change: ▼ Price Decrease of -0.61 (-10.20%)
As of 03/5/2026 05:00 PM ET

This chart shows the closing price history over time for LONA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Athira Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/4/2026Martin Javier SanInsiderSell1,720$5.37$9,236.4015,887View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Athira Pharma (NASDAQ:LONA)

57.12% of Athira Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Athira Pharma logo
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.
Read More on Athira Pharma

Today's Range

Now: $5.37
Low: $5.36
High: $6.06

50 Day Range

MA: N/A

52 Week Range

Now: $5.37
Low: $2.20
High: $8.36

Volume

121,497 shs

Average Volume

52,719 shs

Market Capitalization

$21.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.68

Who are the company insiders with the largest holdings of Athira Pharma?

Athira Pharma's top insider investors include:
  1. Martin Javier San (Insider)
Learn More about top insider investors at Athira Pharma.